We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Navamedic Asa | LSE:0FDB | London | Ordinary Share | NO0010205966 | NAVAMEDIC ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.10 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 512M | 3.3M | 0.1904 | 63.55 | 209.97M |
OSLO, Norway, June 2, 2022 /PRNewswire/ -- The Annual General Meeting of Navamedic ASA was held today at 13:00 CEST. All items on the agenda were resolved in accordance with the board of directors' proposals and the nomination committee's recommendations. A copy of the minutes from the Annual General Meeting are attached to this notice and will also be made available at the Company's webpage www.navamedic.com.
This information is subject of the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
For further information, please contact:
Kathrine G. Andreassen, CEO, Navamedic, Mobile: +47 951 78 680 E-mail: kathrine@navamedic.com
Lars Hjarrand, CFO, Navamedic, Mobile: +47 917 62 842 E-mail: lars.hjarrand@navamedic.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/navamedic-asa/r/navamedic-asa--minutes-of-annual-general-meeting,c3579069
The following files are available for download:
https://mb.cision.com/Main/17619/3579069/1588115.pdf | Navamedic ASA AGM Minutes 2022 |
Copyright 2022 PR Newswire
1 Year Navamedic Asa Chart |
1 Month Navamedic Asa Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions